All Published Articles
Browse our complete catalog of 18 in-depth investigative dossiers, clinical trial readouts, and scientific breakthroughs across the frontiers of biology and biotechnology.
Rewriting the Epigenetic Clock: Can Partial Reprogramming Reverse Human Tissue Aging?
For decades, cellular aging was viewed as an irreversible thermodynamic decline. Today, epigenetic reprogramming is transforming senescence from an inevitable fate into an engineering challenge.
From Code to Crystal: Inside the Fully Autonomous Generative Drug Foundry
Physical pipettes are giving way to acoustic liquid handlers driven by reinforcement learning agents, collapsing the lead discovery pipeline from 4 years to 14 days.
Prime Editing 3.0: Erasing Monogenic Neurological Mutations In Vivo
Double-strand breaks and random indels have plagued clinical CRISPR. The latest generation of engineered pegRNA architectures eliminates off-target cleavage entirely.
The Industrial Microbe: Microbial Fermentation Replaces Petrochemical Polymers
Spider silk, aerospace composites, and performance textiles are being grown inside stainless steel bioreactors at costs rivaling synthetic plastics.
The Q3 BioCapital Report: $14B Deployed into Next-Gen Conjugates and Degitizers
An exclusive breakdown of global life science venture allocations, private valuations, and the reopening of the public biotech IPO window.
Light Over Silicon: Optogenetic Neural Interfaces Restore Lost Motor Pathways
Silicon electrodes degrade inside brain tissue. Wireless infrared optogenetics is offering a biocompatible bridge between intention and robotic actuation.
